Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,560 | -1,890 | -9,500 | -4,250 | -4,940 |
| Depreciation Amortization | 1,760 | 850 | 3,690 | 2,590 | 1,720 |
| Other Working Capital | 1,460 | -1,000 | -1,030 | -4,690 | -1,630 |
| Other Operating Activity | -300 | 190 | 300 | 740 | -70 |
| Operating Cash Flow | $-1,640 | $-1,850 | $-6,540 | $-5,610 | $-4,920 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,270 | -770 | -16,750 | -14,810 | -5,080 |
| Other Investing Activity | -11,620 | 1,600 | 37,980 | 52,560 | 14,530 |
| Investing Cash Flow | $-12,890 | $830 | $21,230 | $37,750 | $9,450 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 820 | 460 | 3,940 | 3,330 | 2,920 |
| Financing Cash Flow | $820 | $460 | $3,940 | $3,330 | $2,920 |
| Beginning Cash Position | 27,900 | 27,900 | 9,260 | 9,260 | 9,260 |
| End Cash Position | 14,190 | 27,350 | 27,900 | 44,740 | 16,710 |
| Net Cash Flow | $-13,710 | $-550 | $18,640 | $35,470 | $7,440 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,640 | -1,850 | -6,540 | -5,610 | -4,920 |
| Free Cash Flow | -1,640 | -1,850 | -6,540 | -5,610 | -4,920 |